
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
Keywords: آئروسل; Cystic fibrosis; Antibiotics; Pseudomonas; Aerosol; Fluoroquinolone;